Frederick Wayne Holtsberg
8Patents
2h-index
15Co-inventors
48Inventor score
Filing activity: May 4, 2000 → Feb 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6913915B2 | PEG-modified uricase | Human Necessities | 68 | Expired |
| US6635462B1 | Mutated form of arginine deiminase | Emerging Cross-Sectional Technologies | 18 | Expired |
| US9815872B2 | Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof | Human Necessities | 2 | Active |
| US10174085B2 | Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof | Human Necessities | 1 | Active |
| US11186626B2 | Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop | Chemistry; Metallurgy | 0 | Active |
| US11826412B2 | Immunogenic composition comprising a fusion peptide derived from superantigen toxoids | Emerging Cross-Sectional Technologies | 0 | Active |
| US11260120B2 | Immunogenic composition comprising a fusion peptide derived from superantigen toxoids | Emerging Cross-Sectional Technologies | 0 | Active |
| US10611827B2 | Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.